AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies
AstraZeneca shares turned negative Wednesday after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.
The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.
Shares of AstraZeneca, a front-runner in the Covid-19 vaccine race, gave up a slight gain after the news broke. Shares were down by about 1% in early afternoon trading.
A spokesperson from AstraZeneca declined to comment on the volunteer, citing “medical confidentiality and clinical trial regulations.”
The spokesperson added that ”[a]ll significant medical events are carefully assessed by trial investigators” and ”[t]hese assessments have not led to any concerns about continuation of the ongoing study.”
Reference: CNBC
Thai
Eng